HDAC9 and glioblastoma: To demonstrate that TINPAT induction upon DAC and HDACi treatment is not restricted to NCI-H1299 cells, we performed DNMT and HDAC inhibition in a large panel of cancer cell lines of several tissue types and cancer entities, including lung cancer, acute myeloid leukemia, glioblastoma, and colon cancer.